Sidra Medicine, a member of Qatar Foundation, has been formally designated as a ZEISS labs@location Reference Customer through its Advanced Imaging Core (AIC).
Sidra Medicine, a member of Qatar Foundation, is advancing orthopedic care in Qatar with the introduction of a specialized pediatric orthopedic sports medicine service. The latest offering from the Orthopedics Department, delivers growth-sparing surgical techniques, tailored for children and young adults.
Sidra Medicine, is developing a new Sensory Integration Gym as part of its continued expansion of specialized pediatric rehabilitation services. The gym will provide an advanced therapeutic environment for children with neurodevelopmental, behavioral, and sensory processing challenges.
Msheireb Museums and Sidra Medicine hosted the second session of the 2026 Science Café series on Monday, which convened leading experts who discussed neurodevelopmental conditions from the perspective of science, technology, ability and achievement under the theme “Different Abilities, Shared Futures: Disability and Success.”
Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a of a limited number of hospitals in the world, to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-based gene therapy treatment.
Sidra Medicine, has successfully performed a sacral neuromodulation implantation procedure on an eight-year-old child with spina bfida.
To mark World Health Day on April 7, Sidra Medicine reinforces its role as a research-driven, patient-centered healthcare organization by announcing its latest service launches and expansion plans for 2026.
Sidra Medicine, a member of Qatar Foundation, has provided specialized treatment to a child from Egypt diagnosed with Duchenne Muscular Dystrophy (DMD).
Sidra Medicine, Qatar’s specialist women’s and children’s hospital and a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six year old patient with a rare genetic condition.
